T4 bacteriophage-mediated inhibition of adsorption and replication of human adenovirus in vitro

Future Microbiology

Volumn 10, Issue 4, 2015, Pages 453-460

  Przybylski, Maciej ^a   Borysowski, Jan ^a   Jakubowska Zahorska, Renata ^a   Weber Dąbrowska, Beata ^b   Górski, Andrzej ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

adenovirus; adsorption; antiviral effects; integrin; phage; replication; T4

Indexed keywords

A549 CELL LINE; ARTICLE; DOSE RESPONSE; ENTEROBACTERIA PHAGE T4; HEK293 CELL LINE; HUMAN ADENOVIRUS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; VIRION; VIRUS ATTACHMENT; VIRUS REPLICATION; CELL LINE; EPITHELIUM CELL; HUMAN; HUMAN ADENOVIRUS C; MONOCYTE; PHYSIOLOGY; VIROLOGY; VIRUS INTERFERENCE; VIRUS LOAD;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

ADENOVIRUSES, HUMAN; BACTERIOPHAGE T4; CELL LINE; EPITHELIAL CELLS; HUMANS; MONOCYTES; VIRAL INTERFERENCE; VIRAL LOAD; VIRUS ATTACHMENT; VIRUS REPLICATION;

EID: 84927765263     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.14.147     Document Type: Article

References (32)

1. Ackermann H-W, W?grzyn G. General characteristics of bacteriophages. In: Phage Therapy. Current Research and Applications. Borysowski J, Midzybrodzki R, Górski A (Eds). Caister Academic Press, Poole, UK, 3-22, (2014).
2. Górski A, Miedzybrodzki R, Borysowski J et al. Bacteriophage therapy for the treatment of infections. Curr. Opin. Investig. Drugs 10(8), 766-774 (2009).
3. Wittebole X, De Roock S, Opal SM. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5(1), 226-235 (2014).
4. Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, Gorski A. Bacterial viruses against viruses pathogenic for man? Virus Res. 110(1-2), 1-8 (2005).
5. Roucourt B, Lavigne R. The role of interactions between phage and bacterial proteins within the infected cell: a diverse and puzzling interactome. Environ. Microbiol. 11(11), 2789-2805 (2009).
6. Lavigne R, Lecoutere E, Wagemans J et al. A multifaceted study of Pseudomonas aeruginosa shutdown by virulent podovirus LUZ19. mBio 4(2), e00061-13 (2013).
7. Mori K, Kubo T, Kibayashi Y, Ohkuma T, Kaji A. Anti-vaccinia virus effect of M13 bacteriophage DNA. Antiviral Res. 31(1-2), 79-86 (1996).
8. Gorski A, Dabrowska K, Switala-Jele K et al. New insights into the possible role of bacteriophages in host defense and disease. Med. Immunol. 2(1), 2 (2003).
9. Boratyski J, Syper D, Weber-Dabrowska B, ?usiak-Szelachowska M, Poniak G, Górski A. Preparation of endotoxin-free bacteriophages. Cell. Mol. Biol. Lett. 9(2), 253-259 (2004).
10. Sharma A, Li X, Bangari DS, Mittal SK. Adenovirus receptors and their implications in gene delivery. Virus Res. 143(2), 184-194 (2009).
11. Lynch JP 3rd, Fishbein M, Echavarria M. Adenovirus. Semin. Respir. Crit. Care Med. 32(4), 494-511 (2011).
12. Leiman PG, Kanamaru S, Mesyanzhinov VV, Arisaka F, Rossmann MG. Structure and morphogenesis of bacteriophage T4. Cell. Mol. Life Sci. 60(11), 2356-2370 (2003).
13. Mesyanzhinov VV, Leiman PG, Kostyuchenko VA et al. Molecular architecture of bacteriophage T4. Biochemistry (Mosc.) 69(11), 1190-1202 (2004).
14. Dabrowska K, Opolski A, Wietrzyk J et al. Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway. Acta Virol. 48(4), 241-248 (2004).
15. Górski A, Midzybrodzki R, Borysowski J et al. Phage as a modulator of immune responses: practical implications for phage therapy. Adv. Virus Res. 83, 41-71 (2012).
16. Stewart PL, Nemerow GR. Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol. 15(11), 500-507 (2007).
17. Bledzka K, Smyth SS, Plow EF. Integrin ?IIb?3: from discovery to efficacious therapeutic target. Circ. Res. 112(8), 1189-1200 (2013).
18. Scarborough RM, Naughton MA, Teng W et al. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J. Biol. Chem. 268(2), 1066-1673 (1993).
19. Lele M, Sajid M, Wajih N, Stouffer GA. Eptifibatide and 7E3, but not tirofiban inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin. Circulation 104(5), 582-587 (2001).
20. Scarborough RM, Rose JW, Hsu MA et al. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 266(15), 9359-9362 (1991).
21. Bateman A, Eddy SR, Mesyanzhinov VV. A member of the immunoglobulin superfamily in bacteriophage T4. Virus Genes 14(2), 163-165 (1997).
22. Fraser JS, Yu Z, Maxwell KL, Davidson AR. Ig-like domains on bacteriophages: a tale of promiscuity and deceit. J. Mol. Biol. 359(2), 496-507 (2006).
23. Halaby DM, Mornon JP. The immunoglobulin superfamily: an insight on its tissular, species, and functional diversity. J. Mol. Evol. 46(4), 389-400 (1998).
24. Aricescu AR, Jones EY. Immunoglobulin superfamily cell adhesion molecules: zippers and signals. Curr. Opin. Cell. Biol. 19(5), 543-550 (2007).
25. de Fougerolles A, Springer TA. Ideas crystallized on immunoglobulin superfamilyintegrin interactions. Chem. Biol. 2(10), 639-43 (1995).
26. Hall H, Hubbell JA. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. Microvasc. Res. 68(3), 169-178 (2004).
27. Arpaia N, Barton GM. Toll-like receptors: key players in antiviral immunity. Curr. Opin. Virol. 1(6), 447-454 (2011).
28. Hashiguchi S, Yamaguchi Y, Takeuchi O, Akira S, Sugimura K. Immunological basis of M13 phage vaccine: regulation under MyD88 and TLR9 signaling. Biochem. Biophys. Res. Commun. 402(1), 19-22 (2010).
29. Eriksson F, Tsagozis P, Lundberg K et al. Tumor-specific bacteriophages induce tumor destruction through activation of tumorassociated macrophages. J. Immunol. 182(5), 3105-3111 (2009).
30. Borecky L, Buchvald J, Adlerova E et al. Results of a five-year study of the curative effect of double stranded ribonucleic acid in viral dermatoses and eye diseases. Adv. Exp. Med. Biol. 110, 175-191 (1978).
31. Kolonin MG, Sun J, Do KA et al. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J. 20(7), 979-981 (2006).
32. Hajitou A, Rangel R, Trepel M et al. Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat. Protoc. 2(3), 523-531 (2007).